24–25 November 2026
5th Annual
EUROPEAN BIOMANUFACTURING SUMMIT
Hotel Maritim Düsseldorf - Düsseldorf, Germany
Featured Speakers


Florence Brunel Veilleux, Ph.D.
SVP and Global Head, MSAT
Sanofi

Hans-Peter Grau
SVP and Head, Global Biotech Manufacturing
Merck Group

Tongtong Wang
SVP and Global Head, Technical Development
Roche

Sarah Dayre
SVP, EMEA Supply
AstraZeneca

Geoffrey Pot
SVP, Global Manufacturing Sciences and Technology
Takeda

Ulla Grove Krogsgaard Thomsen
Chief Executive Officer
Novo Nordisk Pharmatech AS
About the European Biomanufacturing Summit
Our European Biomanufacturing Summit is designed to provide biopharmaceutical and biomanufacturing executives with current trends in biotechnology and pharmaceuticals, advances in cell and gene therapy, and CMC pharmaceutical development. The strategic insights regarding biotechnological developments, best practices in manufacturing, drug delivery, outsourcing, capacity management, quality assurance, quality control, regulatory compliance, operational excellence, supply chain, and logistics are among the topics that will be covered.
What sets our executive biomanufacturing conference apart from other biotechnology conferences is its specially curated program and C-Suite and VP-level speakers. We’ve designed the optimal platform to learn about the latest trends in biotechnology in Europe and global biomanufacturing insights. Network with over 250 of your fellow biopharma leaders, as we explore strategies to maximise efficiency while remaining compliant in this ever-evolving environment at the 2026 European Biomanufacturing Summit.



















































